Could light therapy help treat Alzheimer's?

Publicly released:
International
Photo by Rad Cyrus on Unsplash
Photo by Rad Cyrus on Unsplash

Light therapy might improve symptoms of Alzheimer’s disease, according to international researchers who analysed 15 studies published between 2005 and 2022. The analysis, which included a combined 598 patients in seven countries, found light therapy improved sleep efficiency, improved the consistency and stability of their body clocks and daily activity, alleviated depression, and reduced agitation and caregiver burden. While larger studies are needed, the team says the results indicate light therapy could be a promising treatment option for some symptoms of Alzheimer’s disease.

Media release

From: PLOS

Light therapy may improve symptoms of Alzheimer’s disease

New meta-analysis included fifteen randomized controlled trials involving 598 patients with Alzheimer’s disease and found improvements in sleep and psycho-behavioral symptoms.

Light therapy leads to significant improvements in sleep and psycho-behavioral symptoms for patients with Alzheimer’s disease, according to a new study published this week in the open-access journal PLOS ONE by Qinghui Meng of Weifang Medical University, China, and colleagues.

The cognitive decline associated with Alzheimer’s disease is often accompanied by sleep disturbances and psycho-behavioral symptoms including apathetic and depressive behavior, agitation and aggression. Photobiomodulation is a non-pharmacological therapy that uses light energy to stimulate the suprachiasmic nucleus (SCN), a sleep modulator in the brain. Despite light therapy receiving increased attention as a potential intervention for Alzheimer’s, a systematic evaluation of its efficacy and safety has been unavailable.

In the new study, researchers searched multiple research databases to identify all randomized controlled trials related to light therapy intervention for Alzheimer’s disease or dementia. Fifteen high-quality trials with available methods and relevant outcomes were selected for further analysis. The included trials were written in English, published between 2005 and 2022, and performed in seven countries. They included a combined 598 patients.

The meta-analysis of all fifteen trials found that light therapy significantly improved sleep efficiency, increased interdaily stability (a measure of the strength of circadian rhythms), and reduced intradaily variability (a measure of how frequently someone transitions between rest and activity during the day). In patients with Alzheimer’s disease, light therapy also alleviated depression and reduced patient agitation and caregiver burden.

Given the limited sample sizes in studies included in this meta-analysis, the authors advocate for larger future studies, which could also explore if bright light exposure could cause any adverse behavior in patients. They conclude that light therapy is a promising treatment option for some symptoms of Alzheimer’s disease.  

The authors add: “Light therapy improves sleep and psycho-behavioral symptoms in patients with Alzheimer's disease and has relatively few side effects, suggesting that it may be a promising treatment option for patients with Alzheimer's disease.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research PLOS, Web page The URL will go live after the embargo lifts.
Journal/
conference:
PLOS ONE
Research:Paper
Organisation/s: Weifang Medical University, China
Funder: This work was supported by the Natural Science Foundation of Shandong Province (ZR2020MH128).
Media Contact/s
Contact details are only visible to registered journalists.